The Mole
Guest
The Mole
Guest
All,
The August dates from the fake HR person are bogus. There are talks about streamlining channels. This will primarily be based on the last two years performance "COE Rankings" and managers individual scoring of skill sets.
Much is still pending based on FDA Approval of ZS-9 related to the manufacturing sites passing FDA inspection. ZS Pharma team is definitely out, however. Discussions seem to be a reduction in CVMD between 20-40%.
- The Mole
The August dates from the fake HR person are bogus. There are talks about streamlining channels. This will primarily be based on the last two years performance "COE Rankings" and managers individual scoring of skill sets.
Much is still pending based on FDA Approval of ZS-9 related to the manufacturing sites passing FDA inspection. ZS Pharma team is definitely out, however. Discussions seem to be a reduction in CVMD between 20-40%.
- The Mole